ACIST Medical Systems Announces Approval and Launch of Next-Generation FFR SystemRead more
ACIST Launches Direct Sales of its CVi Contrast Delivery System in JapanRead more
Impact of Post-Intervention Fractional Flow Reserve Measurement on Acute PCI Outcomes Investigated in Large Independent RegistryRead more
Head-to-Head Study Validates Consistent Performance of Microcatheter FFRRead more
ACIST Japan Launches ACIST HDi® High Definition IVUSRead more
Enrollment Complete for ACIST-FFR Multi-Center StudyRead more
ACIST Inc., Announces ACIST Japan Inc., Will Take Over Distribution of CVi Contrast Delivery Injector in JapanView press release
Junichi Osawa appointed to lead ACIST’s injector business in Japan together with valued partner DVx Inc.
ACIST Japan facility opens.
ACIST Japan, K.K is established.
Launches the ACIST CVI® Contrast Delivery System, combining the capabilities of the CMS and Voyager® into one integrated system.
Renamed ACIST (Automated Contrast Injection System Technology) Medical Systems to better reflect the company’s focus.
Licenses five-year marketing rights to New Jersey-based Bracco Diagnostics Inc., which has a nationwide distribution network.
Company is founded by Dr. Robert (Bob) F. Wilson, Professor of Medicine and Director of the Interventional Cardiology Program at the University of Minnesota.
© 2022 ACIST Medical Systems. All rights reserved.